Literature DB >> 11600555

The CAG repeat polymorphism in the AR gene affects high density lipoprotein cholesterol and arterial vasoreactivity.

M Zitzmann1, M Brune, B Kornmann, J Gromoll, S von Eckardstein, A von Eckardstein, E Nieschlag.   

Abstract

Genomic effects of T are exerted via the AR. The length of the polymorphic CAG repeat sequence in the AR gene is inversely correlated with the transcriptional regulation of target genes by T. In 110 healthy men (20-50 yr), we investigated the interactions among this polymorphism, serum levels of sex hormones, cardiovascular risk factors, and flow-mediated and nitrate-induced vasodilatation of the brachial artery. The number of CAG repeat had no significant correlations with serum concentrations of total or free T. Stepwise multiple regression analysis revealed positive correlations of the number of CAG repeat with serum levels of high density lipoprotein cholesterol (partial r = 0.44; P < 0.001) and flow-mediated vasodilatation (partial r = 0.37; P < 0.001). The association of CAG repeat with high density lipoprotein (HDL) cholesterol was independent of body fat content and serum levels of free T, which both had significant negative correlations with HDL cholesterol. The association of CAG repeat with flow-mediated vasodilatation was independent of cigarette smoking and serum levels of free T and low density lipoprotein cholesterol, which also were correlated with flow-mediated vasodilatation. We conclude that a low number of CAG repeat in the AR gene implies a greater chance for low levels of HDL cholesterol and reduced endothelial response to ischemia, which are both important risk factors for coronary heart disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11600555     DOI: 10.1210/jcem.86.10.7889

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  28 in total

1.  A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.

Authors:  Sara Lindström; Jing Ma; David Altshuler; Edward Giovannucci; Elio Riboli; Demetrius Albanes; Naomi E Allen; Sonja I Berndt; Heiner Boeing; H Bas Bueno-de-Mesquita; Stephen J Chanock; Alison M Dunning; Heather Spencer Feigelson; J Michael Gaziano; Christopher A Haiman; Richard B Hayes; Brian E Henderson; David J Hunter; Rudolf Kaaks; Laurence N Kolonel; Loic Le Marchand; Carmen Martínez; Kim Overvad; Afshan Siddiq; Meir Stampfer; Pär Stattin; Daniel O Stram; Michael J Thun; Dimitrios Trichopoulos; Rosario Tumino; Jarmo Virtamo; Stephanie J Weinstein; Meredith Yeager; Peter Kraft; Matthew L Freedman
Journal:  J Clin Endocrinol Metab       Date:  2010-06-09       Impact factor: 5.958

2.  Androgens and vascular function.

Authors:  M Zitzmann; E Nieschlag
Journal:  J Endocrinol Invest       Date:  2003-08       Impact factor: 4.256

Review 3.  Effects of androgen replacement on metabolism and physical performances in male hypogonadism.

Authors:  M Zitzmann; E Nieschlag
Journal:  J Endocrinol Invest       Date:  2003-09       Impact factor: 4.256

4.  Endogenous estrogen levels are associated with endothelial function in males independently of lipid levels.

Authors:  Katerina Saltiki; George Papageorgiou; Paraskevi Voidonikola; Emily Mantzou; Konstantinos Xiromeritis; Christos Papamichael; Maria Alevizaki; Kimon Stamatelopoulos
Journal:  Endocrine       Date:  2010-01-16       Impact factor: 3.633

5.  Expression of humoral autoimmunity is related to androgen receptor CAG repeat length in men with systemic lupus erythematosus.

Authors:  Alex H Tessnow; Nancy J Olsen; William J Kovacs
Journal:  J Clin Immunol       Date:  2011-03-29       Impact factor: 8.317

6.  Investigation of hormone receptor genes in migraine.

Authors:  Natalie J Colson; Rod A Lea; Sharon Quinlan; John MacMillan; Lyn R Griffiths
Journal:  Neurogenetics       Date:  2005-01-15       Impact factor: 2.660

7.  Evaluation of CAG repeat length of androgen receptor expressing cells in human testes showing different pictures of spermatogenic impairment.

Authors:  Daniela Fietz; Joachim Geyer; Sabine Kliesch; Jörg Gromoll; Martin Bergmann
Journal:  Histochem Cell Biol       Date:  2011-10-25       Impact factor: 4.304

8.  Androgen receptor (CAG)n polymorphism and androgen levels in women with systemic lupus erythematosus and healthy controls.

Authors:  Ralitsa Robeva; Dobromir Tanev; Silvia Andonova; Georgi Kirilov; Alexey Savov; Milena Stoycheva; Analia Tomova; Philip Kumanov; Rasho Rashkov; Zlatimir Kolarov
Journal:  Rheumatol Int       Date:  2013-02-07       Impact factor: 2.631

9.  Salivary testosterone and a trinucleotide (CAG) length polymorphism in the androgen receptor gene predict amygdala reactivity in men.

Authors:  Stephen B Manuck; Anna L Marsland; Janine D Flory; Adam Gorka; Robert E Ferrell; Ahmad R Hariri
Journal:  Psychoneuroendocrinology       Date:  2010-01       Impact factor: 4.905

10.  Ethnical disparities of prostate cancer predisposition: genetic polymorphisms in androgen-related genes.

Authors:  Jie Li; Emma Mercer; Xin Gou; Yong-Jie Lu
Journal:  Am J Cancer Res       Date:  2013-04-03       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.